J Korean Ophthalmol Soc > Volume 55(7); 2014 > Article
Journal of the Korean Ophthalmological Society 2014;55(7):1093-1098.
DOI: https://doi.org/10.3341/jkos.2014.55.7.1093    Published online July 15, 2014.
A Case of Adult-Onset Vitelliform Dystrophy Treated with Intravitreal Injection of Bevacizumab.
Sang Woo Moon, Ho Young Lee, Il Han Yun, Sung Hyup Lim
1Department of Ophthalmology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea. klimt99@naver.com
2Therapeutics Center for Ocular Neovascular Disease, Busan, Korea.
3Shinsegae Eye Clinic, Busan, Korea.
노른자모양황반변성 환자에서 유리체강내 베바시주맙 주입술을 시행한 환자 1예
문상우1,2⋅이호영3⋅윤일한1⋅임성협1,2
Department of Ophthalmology, Inje University Busan Paik Hospital, Inje University College of Medicine1, Busan, Korea Therapeutics Center for Ocular Neovascular Disease2, Busan, Korea Shinsegae Eye Clinic3, Busan, Korea
Abstract
PURPOSE
To report a patient diagnosed with adult-onset vitelliform dystrophy (AOVD) who received an intravitreal injection of bevacizumab in both eyes. CASE SUMMARY: A 47-year-old female presented with blurred vision and metamorphopsia in both eyes. On color fundus photograph, small, round, yellowish dots on the foveola and subreitnal fluid were observed. Optical coherence tomography (OCT) showed thick hyperreflective structures in the retinal pigment epithelium (RPE) layer with serous retinal detachment and subretinal fluid. Despite an intravitreal injection of bevacizumab on both eyes, anatomical improvement was not observed on fundus photography and OCT.
Key Words: Bevacizumab;Vitelliform macular dystrophy


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603    Fax: +82-2-2277-5194    E-mail: kos@ijpnc.com                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next